{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:48:47Z","timestamp":1791895727826,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1053\/j.jvca.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:18:50Z","timestamp":1783178330000},"page":"3799-3807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia: A Brief Review and Practical Algorithm"],"prefix":"10.1053","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2281-3435","authenticated-orcid":false,"given":"Vinicius","family":"Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Ligocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ligocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaella","family":"Litvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luai","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Alfirevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2026.07.009_bib0001","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.jvca.2013.07.021","article-title":"Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: An analysis of the nationwide inpatient sample","volume":"28","author":"Seigerman","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.07.009_bib0002","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.athoracsur.2020.10.046","article-title":"Outcomes with heparin-induced thrombocytopenia after cardiac surgery","volume":"112","author":"Brown","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0003","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.athoracsur.2022.07.049","article-title":"Heparin-induced thrombocytopenia after cardiac surgery\u2014a statewide review of health care utilization","volume":"117","author":"Yesantharao","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0004","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood-2016-01-635003","article-title":"How I treat patients with a history of heparin-induced thrombocytopenia","volume":"128","author":"Warkentin","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2026.07.009_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.jvca.2018.10.035","article-title":"Heparin-induced thrombocytopenia: A review for cardiac anesthesiologists and intensivists","volume":"33","author":"Ivascu","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.07.009_bib0006","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-0037-1602664","article-title":"Heparin-induced thrombocytopenia in cardiac surgery patients","volume":"43","author":"Pishko","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2026.07.009_bib0007","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2026.07.009_bib0008","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: A focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.jvca.2026.07.009_bib0009","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: Heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1053\/j.jvca.2026.07.009_bib0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/hematology.2021000289","article-title":"Heparin-induced thrombocytopenia and cardiovascular surgery","volume":"2021","author":"Pishko","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.jvca.2026.07.009_bib0011","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2004-831048","article-title":"Interactions of platelet factor 4 with the vessel wall","volume":"30","author":"Sachais","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2026.07.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100283","article-title":"Heparin-induced thrombocytopenia: An illustrated review","volume":"7","author":"May","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.07.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2026.07.009_bib0014","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.athoracsur.2003.09.034","article-title":"Heparin-induced thrombocytopenia and cardiac surgery","volume":"76","author":"Warkentin","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.122.1.37","article-title":"Heparin-induced thrombocytopenia: Temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin","volume":"122","author":"Lubenow","year":"2002","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2026.07.009_bib0016","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1378\/chest.104.5.1436","article-title":"Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass","volume":"104","author":"Singer","year":"1993","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2026.07.009_bib0017","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1111\/j.1538-7836.2010.04059.x","article-title":"The HIT Expert Probability (HEP) Score: A novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion","volume":"8","author":"Cuker","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.07.009_bib0018","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1538-7836.2004.00949.x","article-title":"Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass","volume":"2","author":"Lillo-Le Lou\u00ebt","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.07.009_bib0019","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1053\/j.jvca.2022.04.007","article-title":"Comparison of screening scores for heparin-induced thrombocytopenia after cardiopulmonary bypass","volume":"36","author":"Cutler","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.07.009_bib0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/phar.2636","article-title":"Comparison of risk-scoring systems for heparin-induced thrombocytopenia in cardiac surgery patients","volume":"41","author":"Stewart","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.jvca.2026.07.009_bib0021","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jtcvs.2005.09.057","article-title":"A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON study","volume":"131","author":"Dyke","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0022","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.athoracsur.2006.09.038","article-title":"Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: Results of the CHOOSE-ON trial","volume":"83","author":"Koster","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0023","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1051\/ject\/200537296","article-title":"Use of bivalirudin as an anticoagulant during cardiopulmonary bypass","volume":"37","author":"Veale","year":"2005","journal-title":"J Extra Corpor Technol"},{"key":"10.1053\/j.jvca.2026.07.009_bib0024","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/ALN.0000000000001976","article-title":"Argatroban and bivalirudin for perioperative anticoagulation in cardiac surgery","volume":"128","author":"Koster","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2026.07.009_bib0025","article-title":"The use of bivalirudin in patients with renal impairment","volume":"12","author":"Robson","year":"2000","journal-title":"J Invasive Cardiol"},{"key":"10.1053\/j.jvca.2026.07.009_bib0026","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1540-8191.2008.00692.x","article-title":"Effect of modified ultrafiltration on bivalirudin elimination and postoperative blood loss after on-pump coronary artery bypass grafting: Assessment of different filtration strategies","volume":"23","author":"Koster","year":"2008","journal-title":"J Card Surg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1213\/ANE.0b013e3181c3c1cd","article-title":"Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia","volume":"110","author":"Welsby","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1P785","article-title":"Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy","volume":"45","author":"Nagle","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2026.07.009_bib0029","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/j.jvca.2015.08.005","article-title":"Pulmonary endarterectomy under hypothermic circulatory arrest in a patient with heparin-induced thrombocytopenia","volume":"30","author":"Duggal","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.07.009_bib0030","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1213\/01.ANE.0000114072.71353.D5","article-title":"Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia","volume":"98","author":"Stratmann","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0031","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0003-4975(02)04782-3","article-title":"Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: Heparin-induced thrombocytopenia in a high-risk cardiac surgical patient","volume":"75","author":"Edwards","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0032","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/vox.13008","article-title":"Clinical outcomes of cardiac surgery patients undergoing therapeutic plasma exchange for heparin-induced thrombocytopenia","volume":"116","author":"Moreno-Duarte","year":"2021","journal-title":"Vox Sang"},{"key":"10.1053\/j.jvca.2026.07.009_bib0033","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1111\/trf.16018","article-title":"Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review","volume":"60","author":"Onuoha","year":"2020","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2026.07.009_bib0034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: The ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1053\/j.jvca.2026.07.009_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2014-07-590844","article-title":"Plasma exchange to remove HIT antibodies: Dissociation between enzyme-immunoassay and platelet activation test reactivities","volume":"125","author":"Warkentin","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2026.07.009_bib0036","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1053\/j.jvca.2024.09.006","article-title":"Efficacy of therapeutic plasma exchange or cangrelor as an adjunctive strategy to facilitate cardiopulmonary bypass in patients with heparin-induced thrombocytopenia: A systematic review and meta-analysis","volume":"38","author":"Del Vecchio","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.07.009_bib0037","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMc1801799","article-title":"Intravenous immune globulin to prevent heparin-induced thrombocytopenia","volume":"378","author":"Warkentin","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2026.07.009_bib0038","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.chest.2017.03.050","article-title":"IVIg for treatment of severe refractory heparin-induced thrombocytopenia","volume":"152","author":"Padmanabhan","year":"2017","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2026.07.009_bib0039","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2019.1636645","article-title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: A review","volume":"12","author":"Warkentin","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1053\/j.jvca.2026.07.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100089","article-title":"Cardiac surgery in acute heparin-induced thrombocytopenia managed with therapeutic plasma exchange and intravenous immunoglobulin","volume":"7","author":"Grazioli","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.07.009_bib0041","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.jvca.2025.08.051","article-title":"Use of high-dose intravenous immunoglobulin as initial therapy for heparin-induced thrombocytopenia in patients with high bleeding risk","volume":"40","author":"Grazioli","year":"2026","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.07.009_bib0042","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1053\/j.jvca.2021.03.037","article-title":"The triple HIT: Perioperative management of heparin-induced thrombocytopenia using plasma exchange, intravenous immunoglobulin, and protamine infusion for left ventricular assist device implantation","volume":"36","author":"Liu","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.07.009_bib0043","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jtcvs.2003.08.042","article-title":"Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost","volume":"127","author":"Palatianos","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0044","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00000542-200102000-00013","article-title":"Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban","volume":"94","author":"Koster","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2026.07.009_bib0045","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mtc.2001.118271","article-title":"One-year experience with the platelet glycoprotein IIb\/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II","volume":"122","author":"Koster","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.07.009_bib0046","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.athoracsur.2017.09.061","article-title":"The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology: Clinical Practice Guidelines\u2014anticoagulation during cardiopulmonary bypass","volume":"105","author":"Shore-Lesserson","year":"2018","journal-title":"Ann Thorac Surg"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026005677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026005677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:07:35Z","timestamp":1791893255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077026005677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1053077026005677"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2026.07.009","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia: A Brief Review and Practical Algorithm","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}